Tested Applications
| Positive WB detected in | HL-60 cells, human peripheral blood leukocyte, PANC-1 cells, THP-1 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
12284-1-AP targets PLAC8 in WB, IHC, IF, CoIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag2939 Product name: Recombinant human PLAC8 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-115 aa of BC012205 Sequence: MQAQAPVVVVTQPGVGPGPAPQNSNWQTGMCDCFSDCGVCLCGTFCFPCLGCQVAADMNECCLCGTSVAMRTLYRTRYGIPGSICDDYMATLCCPHCTLCQIKRDINRRRAMRTF Predict reactive species |
| Full Name | placenta-specific 8 |
| Calculated Molecular Weight | 12 kDa |
| Observed Molecular Weight | 12 kDa |
| GenBank Accession Number | BC012205 |
| Gene Symbol | PLAC8 |
| Gene ID (NCBI) | 51316 |
| RRID | AB_11182285 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NZF1 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
PLAC8, also named as Protein C15, is a placenta-specific protein. The expression was downregulated upon activation, particularly in dendritic cells generated in vitro from CD34 (142230) progenitor cells. The MW of PLAC8 is about 12-20kd.
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for PLAC8 antibody 12284-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The PLAC8 Polyclonal antibody (Cat# 12284-1-AP) has 9 citations spanning journals including Cancer Letters, Cell Communication and Signaling, Frontiers in Immunology, Communications Biology, FASEB Journal, PLoS Genetics, International Journal of Medical Sciences, and Histochemistry and Cell Biology. Research fields cover glioblastoma and temozolomide resistance, monocyte exhaustion, interstitial cystitis biomarkers, colorectal cancer metastasis, pulmonary fibrosis and autophagy, trophoblast biology, placental site trophoblastic tumor, and cervical cancer.
| Species | Application | Title |
|---|---|---|
Cancer Lett Aberrant PLAC8 expression characterizes glioblastoma with temozolomide resistance and an immunosuppressive microenvironment | ||
Front Immunol Identification and validation of immune and diagnostic biomarkers for interstitial cystitis/painful bladder syndrome by integrating bioinformatics and machine-learning | ||
Front Immunol Targeting the CCL28-STAT3-PLAC8 axis to suppress metastasis and remodel tumor microenvironment in colorectal cancer. | ||
Commun Biol PLAC8 attenuates pulmonary fibrosis and inhibits apoptosis of alveolar epithelial cells via facilitating autophagy | ||
FASEB J PLAC8 promotes the autophagic activity and improves the growth priority of human trophoblast cells. |





